An Exploration of the Journey to Diagnosis of Ehlers-Danlos Syndrome (EDS) for Women Living in Australia

Overview

Journal PLoS One

Specialties General Medicine
Science

Date 2024 Jul 25

PMID 39052631

Authors

Rachel Trudgian

Terri Flood

Affiliations

Soon will be listed here.

Abstract

Introduction: Ehlers-Danlos syndromes (EDS) is an umbrella term for a group of hereditary connective tissue disorders usually featuring hyperextensible skin, easy bruising, poor healing, and joint hypermobility. According to international Ehlers-Danlos support groups, the average time to diagnosis of this rare genetic condition is 10-12 years. Consequently, the journey to diagnosis can potentially be traumatic. This pilot study aims to explore female patients' journey to a diagnosis of EDS while living in Australia.

Materials And Methods: Over six weeks, from January to February 2023, a survey was distributed on EDS social media platforms including Facebook and LinkedIn. Ethical approval was obtained through the Ulster University Institute of Nursing and Health Research Ethics Filter Committee (FCNUR). Thematic and statistical analysis of the anonymous data was completed during March 2023.

Results: 152 women completed the survey. More than half of the respondents first noticed symptoms of EDS more than 15 years prior to diagnosis and more than three quarters of respondents received other diagnoses prior to their EDS diagnosis. Most respondents saw their general practitioner, a physiotherapist and/or a rheumatologist prior to being correctly diagnosed with the condition. While some respondents had positive experiences with these health professionals, many felt that they were not listened to and, after doing their own research, had to educate their health professional/s about EDS.

Conclusion: This pilot survey demonstrated that the journey to diagnosis of EDS for women in Australia is frequently long and traumatic. Participants indicated that more EDS education and training is needed for health professionals, especially GPs, to improve the diagnostic process.

Implications For Practice: Participants called for their self-reported symptoms to be listened to by health professionals and to be met with empathy and an open mind instead of being dismissed. Additional education and training to health professionals about connective tissue disorders including EDS may aid earlier diagnosis in Australia.

Citing Articles

Affect Regulation Capabilities in Hypermobility Ehlers Danlos Syndrome: Exploring the Associations with Pain Perception and Psychophysical Health.

Camerota F, Mariani R, Petronelli G, Rabissi B, Vizzini M, Di Trani M Brain Sci. 2025; 15(2).

PMID: 40002533 PMC: 11853494. DOI: 10.3390/brainsci15020202.

References

Halverson C, Clayton E, Garcia Sierra A, Francomano C . Patients with Ehlers-Danlos syndrome on the diagnostic odyssey: Rethinking complexity and difficulty as a hero's journey. Am J Med Genet C Semin Med Genet. 2021; 187(4):416-424. DOI: 10.1002/ajmg.c.31935. View

Tinkle B, Castori M, Berglund B, Cohen H, Grahame R, Kazkaz H . Hypermobile Ehlers-Danlos syndrome (a.k.a. Ehlers-Danlos syndrome Type III and Ehlers-Danlos syndrome hypermobility type): Clinical description and natural history. Am J Med Genet C Semin Med Genet. 2017; 175(1):48-69. DOI: 10.1002/ajmg.c.31538. View

Baeza-Velasco C, Hamonet C, Montalescot L, Courtet P . Suicidal Behaviors in Women With the Hypermobile Ehlers-Danlos Syndrome. Arch Suicide Res. 2021; 26(3):1314-1326. DOI: 10.1080/13811118.2021.1885538. View

Wang Y, Jahani S, Morel-Swols D, Kapely A, Rosen A, Forghani I . Patient experiences of receiving a diagnosis of hypermobile Ehlers-Danlos syndrome. Am J Med Genet A. 2024; 194(8):e63613. DOI: 10.1002/ajmg.a.63613. View

Halverson C, Kroenke K, Penwell H, Francomano C . Evolving Attitudes Toward Numeric Pain Assessment Among Patients with Hypermobile Ehlers-Danlos Syndrome: A Qualitative Interview Study. Pain Med. 2022; 24(6):713-715. PMC: 10501462. DOI: 10.1093/pm/pnac167. View

Ishiguro H, Yagasaki H, Horiuchi Y . Ehlers-Danlos Syndrome in the Field of Psychiatry: A Review. Front Psychiatry. 2022; 12:803898. PMC: 8787077. DOI: 10.3389/fpsyt.2021.803898. View

Castori M . Ehlers-danlos syndrome, hypermobility type: an underdiagnosed hereditary connective tissue disorder with mucocutaneous, articular, and systemic manifestations. ISRN Dermatol. 2012; 2012:751768. PMC: 3512326. DOI: 10.5402/2012/751768. View

Mittal N, Santa Mina D, McGillis L, Weinrib A, Slepian P, Rachinsky M . The GoodHope Ehlers Danlos Syndrome Clinic: development and implementation of the first interdisciplinary program for multi-system issues in connective tissue disorders at the Toronto General Hospital. Orphanet J Rare Dis. 2021; 16(1):357. PMC: 8353438. DOI: 10.1186/s13023-021-01962-7. View

Buchanan E, Hvizdak E . Online survey tools: ethical and methodological concerns of human research ethics committees. J Empir Res Hum Res Ethics. 2009; 4(2):37-48. DOI: 10.1525/jer.2009.4.2.37. View

10.

Halverson C, Penwell H, Francomano C . Clinician-associated traumatization from difficult medical encounters: Results from a qualitative interview study on the Ehlers-Danlos Syndromes. SSM Qual Res Health. 2023; 3. PMC: 10328215. DOI: 10.1016/j.ssmqr.2023.100237. View

11.

Knight D, Confiado S, Bruno K, Fairweather D, Seymour-Sonnier A, Jain A . Establishing an Ehlers-Danlos Syndrome Clinic: Lessons Learned. SN Compr Clin Med. 2022; 4(1):138. PMC: 9255530. DOI: 10.1007/s42399-022-01218-w. View

12.

Malfait F, Wenstrup R, De Paepe A . Clinical and genetic aspects of Ehlers-Danlos syndrome, classic type. Genet Med. 2010; 12(10):597-605. DOI: 10.1097/GIM.0b013e3181eed412. View

13.

Berglund B, Anne-Cathrine M, Randers I . Dignity not fully upheld when seeking health care: experiences expressed by individuals suffering from Ehlers-Danlos syndrome. Disabil Rehabil. 2009; 32(1):1-7. DOI: 10.3109/09638280903178407. View

14.

OConnor S . Designing and Using Surveys in Nursing Research: A Contemporary Discussion. Clin Nurs Res. 2021; 31(4):567-570. PMC: 9014661. DOI: 10.1177/10547738211064739. View

15.

Ruberton P, Huynh H, Miller T, Kruse E, Chancellor J, Lyubomirsky S . The relationship between physician humility, physician-patient communication, and patient health. Patient Educ Couns. 2016; 99(7):1138-1145. DOI: 10.1016/j.pec.2016.01.012. View

16.

Tzartzas K, Oberhauser P, Marion-Veyron R, Bourquin C, Senn N, Stiefel F . General practitioners referring patients to specialists in tertiary healthcare: a qualitative study. BMC Fam Pract. 2019; 20(1):165. PMC: 6885318. DOI: 10.1186/s12875-019-1053-1. View

17.

Malfait F, Castori M, Francomano C, Giunta C, Kosho T, Byers P . The Ehlers-Danlos syndromes. Nat Rev Dis Primers. 2020; 6(1):64. DOI: 10.1038/s41572-020-0194-9. View

18.

Tsang S, Royse C, Terkawi A . Guidelines for developing, translating, and validating a questionnaire in perioperative and pain medicine. Saudi J Anaesth. 2017; 11(Suppl 1):S80-S89. PMC: 5463570. DOI: 10.4103/sja.SJA_203_17. View

19.

Sinibaldi L, Ursini G, Castori M . Psychopathological manifestations of joint hypermobility and joint hypermobility syndrome/ Ehlers-Danlos syndrome, hypermobility type: The link between connective tissue and psychological distress revised. Am J Med Genet C Semin Med Genet. 2015; 169C(1):97-106. DOI: 10.1002/ajmg.c.31430. View

20.

Gazit Y, Jacob G, Grahame R . Ehlers-Danlos Syndrome-Hypermobility Type: A Much Neglected Multisystemic Disorder. Rambam Maimonides Med J. 2016; 7(4). PMC: 5101008. DOI: 10.5041/RMMJ.10261. View